norsalsolinol has been researched along with levodopa in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shirahata, A; Tamura, Z; Yoshioka, M | 1 |
| Klingemann, I; Moser, A; Scholz, J | 1 |
2 other study(ies) available for norsalsolinol and levodopa
| Article | Year |
|---|---|
Fluorometric determination of 1,2,3,4-tetrahydro-6,7-dihydroxyisoquinoline in biological materials by HPLC.
Topics: Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Dopamine Agents; Levodopa; Magnetic Resonance Spectroscopy; Male; Rabbits; Rats; Rats, Wistar; Salsoline Alkaloids; Spectrometry, Fluorescence | 1997 |
Increased systemic levels of norsalsolinol derivatives are induced by levodopa treatment and do not represent biological markers of Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Biomarkers; Chromatography, High Pressure Liquid; Female; Humans; Inactivation, Metabolic; Isoquinolines; Levodopa; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Prospective Studies; Reference Values; Salsoline Alkaloids | 2004 |